FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称REBASTINIB TOSYLATE
异名/同义词2-PYRIDINECARBOXAMIDE, 4-(4-((((3-(1,1-DIMETHYLETHYL)-1-(6-QUINOLINYL)-1H-PYRAZOL-5-YL)AMINO)CARBONYL)AMINO)-3-FLUOROPHENOXY)-N-METHYL-, 4-METHYLBENZENESULFONATE (1:1)
DCC-2036
DP-1919.TO
N-(3-(1,1-DIMETHYLETHYL)-1-(QUINOLIN-6-YL)-1H-PYRAZOL-5-YL)-N'-(2-FLUORO-4-((2-(METHYLCARBAMOYL)PYRIDIN-4-YL)OXY)PHENYL)UREA MONO(4-METHYLBENZENESULFONATE)
REBASTINIB TOSILATE
REBASTINIB TOSILATE [WHO-DD]
REBASTINIB TOSYLATE
REBASTINIB TOSYLATE [USAN]
CAS登记号1033893-29-6
物质唯一标识(Unique Ingredient Identifier)042A5NJE6B
分子式C30H28FN7O3.C7H8O3S
国际化合物标识(International Chemical Identifier,InChI)ARPBZBAWXAVDCE-UHFFFAOYSA-N
SMILESc1(cc(ccn1)Oc2cc(c(cc2)NC(=O)Nc3cc(nn3-c4cc5cccnc5cc4)C(C)(C)C)F)C(=O)NC.c1(ccc(cc1)C)S(=O)(=O)O
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
  • 世界卫生组织药物词典
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System